| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Christopher E Dandoy, MD |
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics |
National Institutes of Health |
R21 CA223503 |
02/02/2018 - 01/31/2020 |
$207,495 |
| Stella M Davies, MD |
Vitamin A to improve Gut Permeability and Reduce Infection and GVHD in Children |
Gateway for Cancer Research |
G17300 |
07/01/2017 - 06/30/2020 |
$119,979 |
| Stella M Davies, MD |
Childhood Cancer Survivor Study |
National Institutes of Health (St Jude's Children's Hospital) |
U24 CA055727 |
12/01/2016 - 11/30/2021 |
$218,151 |
| Alexandra H Filipovich, MD |
Primary Immune Deficiency Treatment Consortium |
National Institutes of Health (The Univ of California, San Francisco) |
U54 AI082973 |
09/01/2014 - 08/31/2019 |
$26,200 |
| Michael B Jordan, MD |
Consortium for Clinical and Translational Research in LCH |
St. Baldrick's Foundation (St Jude's Children's Hospital) |
318937 |
11/09/2015 - 06/30/2018 |
$7,219 |
| Mary C Krupski, DO |
Defining the Impact of Alemtuzumab on Outcomes in Reduced Intensity conditioning Hematopoietic Cell Transplantation of Hemophagocytic Lymphohistiocytosis |
National Institutes of Health (The Univ of California, San Francisco) |
U54 AI082973 |
09/01/2017 - 08/31/2018 |
$27,500 |
| Rebecca A Marsh, MD |
CD38 Bright CD8+ Effector Memory T-cells herald Acute Graft versus Host Disease |
Doris Duke Charitable Foundation |
Marsh, Rebecca, DD |
07/01/2015 - 06/30/2019 |
$162,000 |
| Rebecca A Marsh, MD |
Resources to Assist Investigations in Primary Immunodeficiency Diseases |
National Institutes of Health (US Immunodeficiency Network) |
U24 AI086037 |
04/01/2017 - 03/31/2019 |
$37,464 |
| Parinda Mehta, MD |
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients with FA |
Fanconi Anemia Research Fund |
FARF, Mehta, Parinda |
02/01/2018 - 01/31/2019 |
$75,000 |
| Total Annual Grant Award Dollars |
$881,008 |
